MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Pliant Therapeutics, Inc. Common Stock

PLRX

#3339
Pliant Therapeutics, Inc. Common Stock
1.30
+3.17%
Sector:
Base:
Profit Currency:
Daily Range
1.30
1.30
Year Range
1.09
3.46
Daily Change
+3.17%
Monthly Change
+4.00%
6 month change
-23.08%
Year Change
-59.25%
Previous Close
1.26
Open
1.30
Bid
Ask
Low
1.30
High
1.30
Volume
7
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. PLRX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Seeking Alpha Seeking Alpha
PLRX
2026.02.24
Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration
Investing Investing
PLRX
2026.01.23
Pliant therapeutics CFO Cummings sells $30,722 in stock
Investing Investing
PLRX
2026.01.23
Pliant Therapeutics CHRO Cheung sells $9.6k in stock
Investing Investing
PLRX
2025.12.16
Pliant Therapeutics appoints Minnie Kuo as chief operating officer
Seeking Alpha Seeking Alpha
PLRX
2025.12.09
Pliant Therapeutics, Inc. (PLRX) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow (NASDAQ:PLRX) 2025-12-09
Investing Investing
PLRX
2025.12.08
Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre
Investing Investing
PLRX
2025.12.04
Pliant Therapeutics stock jumps on promising cancer drug trial results
Benzinga Benzinga
PLRX MRK
2025.12.04
Why Is Pliant Therapeutics Stock Trading Lower Today - Pliant Therapeutics (NASDAQ:PLRX)
Investing Investing
PLRX
2025.12.04
Pliant’s PLN-101095 shows promising results in cancer trial
Investing Investing
PLRX
2025.10.24
Pliant Therapeutics announces resignation of chief business officer
Investing Investing
PLRX
2025.10.10
JPMorgan downgrades Pliant Therapeutics stock rating to Underweight from Neutral
Investing Investing
PLRX
2025.08.08
Pliant Therapeutics stock price target slashed by Piper Sandler

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd